Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

Point of Care STI Testing

Study ID: NCT06844045
Start Date: 2026-01-16
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5150

Intervention / Treatment

Gonorrhea/chlamydia Point-of-Care Testing

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

QFR-Based Functional SYNTAX Score System in Optimizing Revascularization Strategy for Multivessel Disease

Study ID: NCT07020195
Start Date: 2026-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Traditional SYNTAX scoring

QFR-Based Functional SYNTAX Score System

Sponsor

First Affiliated Hospital of Harbin Medical University

Source: clinicaltrials.gov

Share:
Add to list

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Study ID: NCT07272603
Start Date: 2025-12-15
End Date: 2026-02-15
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

5

Intervention / Treatment

Plasma-Activated Saline Solution (PASS) Bladder Instillation

Sponsor

Qilu Hospital of Shandong University

Source: clinicaltrials.gov

Share:
Add to list

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Study ID: NCT07258290
Start Date: 2026-05
End Date: 2033-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1859

Intervention / Treatment

Freesolve RMS

Xience DES

Sponsor

Teleflex

Source: clinicaltrials.gov

Share:
Add to list

Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease

Study ID: NCT07280299
Start Date: 2026-05-30
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

111

Intervention / Treatment

Low Dose GT-02287

High Dose GT-02287

Placebo

Sponsor

Gain Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Study ID: NCT07254221
Start Date: 2026-02-01
End Date: 2028-04-21
Study Type

Interventional

Study Phase

Phase4

No. of Participants

400

Intervention / Treatment

Rosuvastatin 20 mg/day

Placebo tablets similar to rosuvastatin 20mg tablets

Sponsor

Shiraz University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian Cities

Study ID: NCT07120477
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

500

Intervention / Treatment

Intravenous Esketamine

Crisis Response Planning intervention (structures safety planning)

Sponsor

University of Sao Paulo

Source: clinicaltrials.gov

Share:
Add to list

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

Study ID: NCT07271238
Start Date: 2026-01-15
End Date: 2026-08-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

VERAFEYE Imaging and Guidance System

Sponsor

LUMA Vision Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Study ID: NCT07277387
Start Date: 2026-01
End Date: 2029-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

Plasma and DNA sample collection for proteomic and genomic analysis

Sponsor

Salamanca Biomedical Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Study ID: NCT07072585
Start Date: 2026-03-30
End Date: 2035-09-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1708

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Bone Scan

Bortezomib

Calaspargase Pegol

Computed Tomography

Cyclophosphamide

Cytarabine

daratumumab

Daunorubicin Hydrochloride

Dexamethasone

Doxorubicin Hydrochloride

Echocardiography Test

Lumbar Puncture

Magnetic Resonance Imaging

Mercaptopurine Oral Suspension

Methotrexate

Methylprednisolone

Nonsense

Pegaspargase

Positron Emission Tomography

Prednisolone

Prednisone

Administration Questionnaire

Radiation Therapy

Therapeutic Hydrocortisone

Thioguanine

Ultrasound Imaging

Vincristine Sulfate

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list